Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia.

Blood cancer journal·2026

Same author

Safety of Ready-to-Eat Green Leafy Salads: Growth Potential of <i>Listeria monocytogenes</i> During Shelf Life.

Foods (Basel, Switzerland)·2026

Same author

Subtype-Specific Risk of Non-Melanoma Skin Cancers in MPN Patients: An Expanded Analysis of the MPN-K Case-Control Database.

American journal of hematology·2026

Same author

Changes in neutrophil-to-lymphocyte ratio in patients with polycythemia vera treated with ruxolitinib reflect <i>JAK2</i> variant allele frequency.

Haematologica·2026

Same author

Polycythemia vera.

Mayo Clinic proceedings·2026

Same author

Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Blood·2026

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Special issues in myeloproliferative neoplasms.

Tiziano Barbui¹, Guido Finazzi

¹Research Foundation, Ospedali Riuniti, Via Garibaldi 13, 24124, Bergamo, Italy. tbarbui@ospedaliriuniti.bergamo.it

Current Hematologic Malignancy Reports

|December 25, 2010

Summary

Special issues in myeloproliferative neoplasms (MPN) present unique challenges in patient care. This review focuses on expert consensus recommendations for managing these complex MPN conditions.

Area of Science:

Hematology
Oncology
Internal Medicine

Background:

Special issues in myeloproliferative neoplasms (MPN) significantly impact patient survival and quality of life.
Current clinical research offers limited evidence for diagnosing and treating these complex MPN cases.
These challenges include MPN during pregnancy, in pediatric patients, abdominal vein thrombosis, bleeding risks, surgical considerations, pruritus, and leukemic transformation.

Purpose of the Study:

To review the current understanding of special issues in myeloproliferative neoplasms.
To emphasize expert consensus recommendations for managing these challenging clinical scenarios.

Main Methods:

Literature review focusing on special issues in myeloproliferative neoplasms.
Analysis of recently developed guidelines based on experts' consensus.

More Related Videos

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Related Experiment Videos

Last Updated: Jun 5, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Main Results:

Practical management strategies for these MPN issues are often empirical.
Expert consensus guidelines provide a framework for clinical decision-making.
The review covers MPN in pregnancy and children, thrombosis, bleeding, surgery, pruritus, and leukemic transformation.

Conclusions:

Addressing special issues in myeloproliferative neoplasms requires specialized approaches.
Expert consensus guidelines are crucial for navigating complex MPN cases.
Further research is needed, but current consensus offers practical support for clinicians.